- Is cyclophosphamide effective in patients with IgM-positive minimal change disease?2012 | Publikace bez příslušnosti k fakultě
- Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience2019 | 1. lékařská fakulta
